Skip to main content
. 2021 Oct 14;480(4):748–758. doi: 10.1097/CORR.0000000000002011

Table 1.

Baseline demographic and clinicopathologic characteristics

Characteristic Dedifferentiated chondrosarcoma (n = 185) Osteosarcoma (n = 2261) p value
Sex
 Male 57 (106) 55 (1252) 0.65
Racea < 0.001
 White or unknown 94 (173) 75 (1703)
 Black 2 (4) 15 (331)
 Other (Native American, Alaska native, Asian, Pacific Islander) 4 (8) 10 (227)
Age in years < 0.001
 Median (range) 66 (18-95) 17 (3-91)
 0-66 51 (94)
 > 66 49 (91)
 0-17 52 (1179)
 > 17 48 (1082)
Size in mm 0.280
 Median (range) 90 (7-420) 90 (4-888)
 ≤ 8 cm 36 (67) 35 (781)
 > 8 cm 50 (92) 47 (1056)
 Missing 14 (26) 19 (424)
SEER stage 0.053
 Local 36 (67) 44 (988)
 Regional 64 (118) 56 (1273)
Tumor grade 0.002
 I and II 10 (19) 6 (141)
 III and IV 78 (144) 73 (1641)
 Missing 12 (22) 21 (479)
Primary tumor location < 0.001
 Extremities 72 (134) 89 (2008)
 Trunk or bone, NOS 28 (51) 11 (253)
Subtype N/A
 Osteosarcoma, NOS 68 (1541)
 Chondroblastic osteosarcoma 16 (356)
 Fibroblastic osteosarcoma 6 (129)
 Telangiectatic osteosarcoma 4 (95)
 Osteosarcoma in Paget disease of bone 1 (16)
 Small cell osteosarcoma 1 (18)
 Central osteosarcoma 4 (92)
 High-grade surface osteosarcoma 1 (14)
Radiation < 0.001
 No/unknown 80 (148) 96 (2160)
 Yes 20 (37) 4 (101)
Chemotherapy < 0.001
 No/unknown 68 (125) 11 (259)
 Yes 32 (60) 89 (2002)

Data presented as % (n), unless otherwise indicated.

a

Self-reported; NOS = not otherwise specified.